Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06429436

Vending Machine Naloxone Distribution for Your Community (VENDY)

Vending Machine Naloxone Distribution for Your Community (VENDY): Increasing Reach and Implementation of Naloxone Distribution

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
4,000 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.

Detailed description

This pilot assessment of the VENDY program will take place in 3 communities. Each community will have a machine (vending or kiosks) in which naloxone will be distributed for free to community members. Our preliminary work identified the locations desired by community members who use illegal drugs for machine placement. The pilot test test will include evaluation of the reach (naloxone distribution), adoption (% of sites and staff implementing), and implementation (fidelity to restocking and maintenance protocol) of VENDY in each community.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVENDYAt least 1 machine (vending machine like a snack machine or a machine like a newspaper kiosk) will be placed in the respective community served by the participating organizations. Any person in the community can get naloxone from the machine. The vending machine will require a code that will be placed on the machine for anyone to use. The kiosks are a box that you simply pull open and naloxone can be obtained. Naloxone kits will be provided for free as part of the current naloxone distribution program within each respective organization.

Timeline

Start date
2024-06-01
Primary completion
2026-01-01
Completion
2026-06-30
First posted
2024-05-28
Last updated
2025-11-13

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06429436. Inclusion in this directory is not an endorsement.